Lv1
60 积分 2024-09-19 加入
Small Cell Lung Cancer A Review
1个月前
已完结
Small Cell Lung Cancer
1个月前
已完结
The next generation of immunotherapies for lung cancers
1个月前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
1个月前
已完结
Emerging Strategies for the Treatment of Small Cell Lung Cancer
1个月前
已完结
Small Cell Lung Cancer
1个月前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
8个月前
已完结
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
9个月前
已完结
Telisotuzumab Vedotin: First Approval
11个月前
已完结
皖公网安备34019202002308
